It is generally accepted that radiotherapy must target clonogenic cells, i.e., those cells in a tumour that have self-renewing potential. Focussing on isolated clonogenic cells, however, may lead to an underestimate or even to an outright neglect of the importance of biological mechanisms that regulate tumour cell sensitivity to radiation. We develop a new statistical and experimental approach to quantify the effects of radiation on cell populations as a whole. In our experiments, we change the proximity relationships of the cells by culturing them in wells with different shapes, and we find that the radiosensitivity of T47D human breast carcinoma cells in tight clusters is different from that of isolated cells. Molecular analyses show that...
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer and tends to de...
Cytokinesis-blocked micronucleus (CBMN) assay has been extensively used to evaluate the radiation se...
Radiotherapy is a key treatment option for breast cancer, yet the molecular responses of normal huma...
It is generally accepted that radiotherapy must target clonogenic cells, i.e., those cells in a tumo...
It is generally accepted that radiotherapy must target clonogenic cells, i.e., those cells in a tumo...
Background: Radiotherapy is an integral part of breast cancer treatment. Immune activating propertie...
AbstractTumor radioresistance leads to recurrence after radiation therapy. The radioresistant phenot...
The concepts of stem cells being resistant to therapy, stem-like cells existing in brain tumors, and...
Intra-tumoural biological, transcriptional and genomic heterogeneity are hallmarks of human breast c...
The major goal of radiotherapy is the induction of tumor cell death. Additionally, radiotherapy can ...
Background Distant metastasis is the leading risk factor of death in breast cancer patients, with lu...
SummaryTissue microenvironment is an important determinant of carcinogenesis. We demonstrate that io...
Background: Radiotherapy, administered in fractionated as well as ablative settings, is an essential...
Tumour cells show a varying susceptibility to radiation damage as a function of the current cell cyc...
Although radiotherapy (RT) decreases the incidence of locoregional recurrence in breast cancer, pati...
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer and tends to de...
Cytokinesis-blocked micronucleus (CBMN) assay has been extensively used to evaluate the radiation se...
Radiotherapy is a key treatment option for breast cancer, yet the molecular responses of normal huma...
It is generally accepted that radiotherapy must target clonogenic cells, i.e., those cells in a tumo...
It is generally accepted that radiotherapy must target clonogenic cells, i.e., those cells in a tumo...
Background: Radiotherapy is an integral part of breast cancer treatment. Immune activating propertie...
AbstractTumor radioresistance leads to recurrence after radiation therapy. The radioresistant phenot...
The concepts of stem cells being resistant to therapy, stem-like cells existing in brain tumors, and...
Intra-tumoural biological, transcriptional and genomic heterogeneity are hallmarks of human breast c...
The major goal of radiotherapy is the induction of tumor cell death. Additionally, radiotherapy can ...
Background Distant metastasis is the leading risk factor of death in breast cancer patients, with lu...
SummaryTissue microenvironment is an important determinant of carcinogenesis. We demonstrate that io...
Background: Radiotherapy, administered in fractionated as well as ablative settings, is an essential...
Tumour cells show a varying susceptibility to radiation damage as a function of the current cell cyc...
Although radiotherapy (RT) decreases the incidence of locoregional recurrence in breast cancer, pati...
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer and tends to de...
Cytokinesis-blocked micronucleus (CBMN) assay has been extensively used to evaluate the radiation se...
Radiotherapy is a key treatment option for breast cancer, yet the molecular responses of normal huma...